Samuel Shrestha, Thomas Samantha, Asleson Louise, Nguyen Anny, Meier Jeffery L, El-Herte Rima
School of Medicine, Creighton University, Omaha, Nebraska, USA.
Iowa City Veterans Affairs Health Care System, Iowa City, Iowa, USA.
Open Forum Infect Dis. 2025 Mar 10;12(3):ofaf144. doi: 10.1093/ofid/ofaf144. eCollection 2025 Mar.
Previously healthy adults hospitalized with an acute undifferentiated illness who test positive for cytomegalovirus (CMV) immunoglobulin M (IgM) in their serum may have a primary CMV infection, CMV reactivation/reinfection, or a false-positive result. We aimed to understand how clinicians interpret and incorporate positive CMV IgM test results into their diagnostic and management decisions.
This was a retrospective case series study of 13 previously healthy, immunocompetent adults hospitalized with an acute illness in a 12-hospital system from 1 January 2017 to 1 January 2020, who tested positive for CMV IgM within 3 days of hospitalization. Twelve of 13 had CMV immunoglobulin G (IgG).
Among these 13 adults (median age, 36 years), elevated liver enzymes (100%), fever (85%), hepatosplenomegaly (54%), and headache (38%) were common. Lymphocytosis was observed in 5 patients, reactive lymphocytes in 3, and 1 patient died from hemophagocytic lymphohistiocytosis. Dual positivity for CMV and Epstein-Barr virus (EBV) IgM was frequent, yet only 1 patient was tested for both CMV and EBV DNA in blood or for CMV IgG avidity index, which indicated a primary CMV infection. Of the 6 patients with CMV DNA in blood, 4 received anti-CMV treatment. Uncertainty regarding CMV's role in the illness was common, and final assessments varied even among cases with similar clinical presentations and serologic patterns.
Interpreting positive CMV IgM results in immunocompetent adults hospitalized with acute illness is challenging and ambiguous due to test limitations and confounders. Supplemental CMV IgG avidity testing can help determine whether primary CMV infection caused the illness, thereby refining the diagnosis and potentially influencing clinical decision-making.
既往健康的成年人因急性未分化疾病住院,其血清中巨细胞病毒(CMV)免疫球蛋白M(IgM)检测呈阳性,可能患有原发性CMV感染、CMV再激活/再感染或假阳性结果。我们旨在了解临床医生如何解读CMV IgM检测阳性结果并将其纳入诊断和管理决策中。
这是一项回顾性病例系列研究,研究对象为2017年1月1日至2020年1月1日期间在一个由12家医院组成的系统中因急性疾病住院的13名既往健康、免疫功能正常的成年人,他们在住院3天内CMV IgM检测呈阳性。13名患者中有12名检测出CMV免疫球蛋白G(IgG)。
在这13名成年人(中位年龄36岁)中,肝酶升高(100%)、发热(85%)、肝脾肿大(54%)和头痛(38%)很常见。5例患者出现淋巴细胞增多,3例出现反应性淋巴细胞,1例患者死于噬血细胞性淋巴组织细胞增生症。CMV和爱泼斯坦-巴尔病毒(EBV)IgM双阳性很常见,但只有1例患者检测了血液中的CMV和EBV DNA或CMV IgG亲和力指数,提示原发性CMV感染。6例血液中检测出CMV DNA的患者中,4例接受了抗CMV治疗。CMV在疾病中的作用存在不确定性很常见,即使在临床表现和血清学模式相似的病例中,最终评估也各不相同。
由于检测局限性和混杂因素,解读因急性疾病住院的免疫功能正常成年人CMV IgM检测阳性结果具有挑战性且不明确。补充CMV IgG亲和力检测有助于确定原发性CMV感染是否导致了疾病,从而完善诊断并可能影响临床决策。